Latest Paclitaxel Stories
SAN DIEGO, June 25, 2014 /PRNewswire/ -- Concortis Biosystems, Inc.
SAN DIEGO, June 20, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Health Canada has reinstated Biolyse Pharma’s Establishment Licence (EL) after sending in a team of inspectors to look at manufacturing within the St.Catharines based Pharmaceutical.
Transparency Market Research added a new report "Drug Eluting Balloons Market: Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019" to its report store.
Two New Therapies Will Match Progression-Free Survival Improvements Required By Surveyed U.S.
SAN DIEGO, May 30, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
A pathway to the design of even more effective versions of the powerful anti-cancer drug Taxol has been opened with the most detailed look ever at the assembly and disassembly of microtubules, tiny fibers of tubulin protein that form the cytoskeletons of living cells and play a crucial role in mitosis.
New comprehensive research report “Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies”
AADi Initiates NIH Funded Clinical Trial for Patients with Bladder Cancer PACIFIC PALISADES, Calif., May 20, 2014 /PRNewswire/ -- AADi, LLC, a clinical stage biopharmaceutical company
RnRMarketResearch.com adds "Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies" to its store. DALLAS,